loreev xr Drug Patent Profile
✉ Email this page to a colleague
When do Loreev Xr patents expire, and what generic alternatives are available?
Loreev Xr is a drug marketed by Almatica and is included in one NDA. There is one patent protecting this drug.
This drug has thirty-five patent family members in thirty countries.
The generic ingredient in LOREEV XR is lorazepam. There are eleven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Loreev Xr
A generic version of loreev xr was approved as lorazepam by SANDOZ on April 21st, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for loreev xr?
- What are the global sales for loreev xr?
- What is Average Wholesale Price for loreev xr?
Summary for loreev xr
International Patents: | 35 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Patent Applications: | 4,700 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for loreev xr |
What excipients (inactive ingredients) are in loreev xr? | loreev xr excipients list |
DailyMed Link: | loreev xr at DailyMed |
![loreev xr drug patent expirations Drug patent expirations by year for loreev xr](/p/graph/s/t/loreev_xr-patent-expirations.png)
![Drug Prices for loreev xr](/p/graph/drug-price/loreev+xr.png)
Pharmacology for loreev xr
Drug Class | Benzodiazepine |
US Patents and Regulatory Information for loreev xr
loreev xr is protected by one US patents.
Patents protecting loreev xr
Sustained release formulations of lorazepam
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: ONCE DAILY TREATMENT OF ANXIETY DISORDER IN ADULTS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-001 | Aug 27, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-003 | Aug 27, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-004 | Feb 16, 2022 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Almatica | LOREEV XR | lorazepam | CAPSULE, EXTENDED RELEASE;ORAL | 214826-002 | Aug 27, 2021 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for loreev xr
See the table below for patents covering loreev xr around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Serbia | 61857 | FORMULACIJE LORAZEPAMA SA PRODUŽENIM OSLOBAĐANJEM (SUSTAINED RELEASE FORMULATIONS OF LORAZEPAM) | ⤷ Sign Up |
Australia | 2014205440 | Sustained release formulations of lorazepam | ⤷ Sign Up |
Hungary | E054005 | ⤷ Sign Up | |
Russian Federation | 2015128915 | СОСТАВЫ ЛОРАЗЕПАМА С ЗАМЕДЛЕННЫМ ВЫСВОБОЖДЕНИЕМ | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |